No products in the cart.
Mouse Monoclonal Anti-Keratin antibody (STJ99231)
Supplier: St John’s Laboratory Ltd.
Recommended applications: WB, ELISA
Recommended dilution: WB 1:500-2000; ELISA 1:10000-20000
Recommended protocols: check protocols
Click or hover above images to see image description for Anti-Keratin antibody.
Check alternative names for the antibodyExpand
|58 kDa cytokeratin antibody|CK-5 antibody|CK5 antibody|Cytokeratin-5 antibody|Cytokeratin5 antibody|DDD antibody|DDD1 antibody|EBS2 antibody|epidermolysis bullosa simplex 2 Dowling-Meara/Kobner/Weber-Cockayne types antibody|K2C5_HUMAN antibody|K5 antibody|keratin 5 (epidermolysis bullosa simplex, Dowling-Meara/Kobner/Weber-Cockayne types) antibody|Keratin 5 antibody|Keratin antibody|keratin complex 2, basic, gene 5 antibody|keratin, type II cytoskeletal 5 antibody|Keratin-5 antibody|Keratin5 antibody|KRT 5 antibody|Krt5 antibody|KRT5A antibody|type II cytoskeletal 5 antibody|Type-II keratin Kb5 antibody|Anti-Cytokeratin 5 antibody [EP1601Y] (ab52635)
SCBT cat No: sc-81702|sc-17090|sc-80606|sc-377431|sc-66856|sc-32721|
|Catalogue No.|| |
Human, Mouse, Rat
Anti-Keratin antibody detects endogenous levels of Keratin (50-60kDa) proteins.
Purified recombinant human KRT5 beta protein fragments expressed in E.coli.
|Recommended dilution|| |
WB 1:500-2000; ELISA 1:10000-20000
|Molecular weight|| |
Anti-Keratin antibody was tube-contained in liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Anti-Keratin antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-20 Celsius degree. Avoid repeated freeze/thaw cycles.
|Alternative antibody names|| |
58 kDa cytokeratin antibody, CK-5 antibody, CK5 antibody, Cytokeratin-5 antibody, Cytokeratin5 antibody, DDD antibody, DDD1 antibody, EBS2 antibody, epidermolysis bullosa simplex 2 Dowling-Meara/Kobner/Weber-Cockayne types antibody, K2C5_HUMAN antibody, K5 antibody, keratin 5 (epidermolysis bullosa simplex, Dowling-Meara/Kobner/Weber-Cockayne types) antibody, Keratin 5 antibody, Keratin antibody, keratin complex 2, basic, gene 5 antibody, keratin, type II cytoskeletal 5 antibody, Keratin-5 antibody, Keratin5 antibody, KRT 5 antibody, Krt5 antibody, KRT5A antibody, type II cytoskeletal 5 antibody, Type-II keratin Kb5 antibody
|Database links|| |
|Involvement in disease|| |
Epidermolysis bullosa simplex, Dowling-Meara type (DM-EBS) [MIM:131760]: A severe form of intraepidermal epidermolysis bullosa characterized by generalized herpetiform blistering, milia formation, dystrophic nails, and mucous membrane involvement. . Note=The disease is caused by mutations affecting the gene represented in this entry.; Epidermolysis bullosa simplex, with migratory circinate erythema (EBSMCE) [MIM:609352]: A form of intraepidermal epidermolysis bullosa characterized by unusual migratory circinate erythema. Skin lesions appear from birth primarily on the hands, feet, and legs but spare nails, ocular epithelia and mucosae. Lesions heal with brown pigmentation but no scarring. Electron microscopy findings are distinct from those seen in the DM-EBS, with no evidence of tonofilament clumping. Note=The disease is caused by mutations affecting the gene represented in this entry.; Epidermolysis bullosa simplex, Weber-Cockayne type (WC-EBS) [MIM:131800]: A form of intraepidermal epidermolysis bullosa characterized by blistering limited to palmar and plantar areas of the skin. . Note=The disease is caused by mutations affecting the gene represented in this entry.; Epidermolysis bullosa simplex, Koebner type (K-EBS) [MIM:131900]: A form of intraepidermal epidermolysis bullosa characterized by generalized skin blistering. The phenotype is not fundamentally distinct from the Dowling-Meara type, although it is less severe. . Note=The disease is caused by mutations affecting the gene represented in this entry.; Epidermolysis bullosa simplex, with mottled pigmentation (MP-EBS) [MIM:131960]: A form of intraepidermal epidermolysis bullosa characterized by blistering at acral sites and 'mottled' pigmentation of the trunk and proximal extremities with hyper- and hypopigmentation macules. . Note=The disease is caused by mutations affecting the gene represented in this entry.; Dowling-Degos disease 1 (DDD1) [MIM:179850]: An autosomal dominant genodermatosis. Affected individuals develop a postpubertal reticulate hyperpigmentation that is progressive and disfiguring, and small hyperkeratotic dark brown papules that affect mainly the flexures and great skin folds. Patients usually show no abnormalities of the hair or nails. . Note=The disease is caused by mutations affecting the gene represented in this entry.
|Protein sequence and domain|| |
Belongs to the intermediate filament family.
|Research area|| |
<a href="http://antibodyplus.com/research-areas/">All research areas</a>><a href="http://antibodyplus.com/Structural-Proteins/">Structural Proteins</a>><a href="http://antibodyplus.com/product-tag/Cytokeratin/">Cytokeratin</a><br><a href="http://antibodyplus.com/product-tag/Structural-Proteins/"> (View all antibody categories related to Structural Proteins)</a>
AntibodyPlus can customize Anti-Keratin antibody according to your requirement, including bulk product size,etc. Please contact <a href="mailto:firstname.lastname@example.org">email@example.com</a>. AntibodyPlus provide antibody trial sample for your own antibody validation and collects antibody reviews.
St John’s Laboratory Ltd.
|Product type|| |
There are no reviews for this product yet.
By submitting a review, get following benefits:
1. Receive $50 ABcoins as credit for each review.
2. First trial sample order will be fully refunded as credit.
3. Have a chance to win a $50 amazon gift card!
There is no extra validation for this product yet.
Check other extra validated antibodies below: